![Lars Grundemar](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Lars Grundemar is currently the Director at Reccan Diagnostics AB. He was previously the Chief Executive Officer at Oncorena AB and Oncorena Holding AB.
| Empresas | Cargo | Inicio |
|---|---|---|
Reccan Diagnostics AB
 Reccan Diagnostics AB Pharmaceuticals: MajorHealth Technology Provides cancer diagnosis and treatment | Director/Miembro de la Junta | - |
| Empresas | Cargo | Fin |
|---|---|---|
Oncorena AB
 Oncorena AB Pharmaceuticals: MajorHealth Technology Develops a novel pharmacological treatment for metastasing clear cell renal cancer | Director Ejecutivo | 20/06/2022 |
Oncorena Holding AB
 Oncorena Holding AB Pharmaceuticals: MajorHealth Technology Develops novel pharmacological treatment for metastasing clear cell renal cancer | Director Ejecutivo | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
Oncorena AB
Oncorena AB Pharmaceuticals: MajorHealth Technology Develops a novel pharmacological treatment for metastasing clear cell renal cancer | Health Technology |
Oncorena Holding AB
Oncorena Holding AB Pharmaceuticals: MajorHealth Technology Develops novel pharmacological treatment for metastasing clear cell renal cancer | Health Technology |
Reccan Diagnostics AB
Reccan Diagnostics AB Pharmaceuticals: MajorHealth Technology Provides cancer diagnosis and treatment | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
